Jade Biosciences (JBIO) Current Leases (2021 - 2025)
Jade Biosciences (JBIO) posted Current Leases of $312000.0 for Q1 2025, down 25.18% on a QoQ basis from $417000.0 in Q4 2024, and down 29.89% year-over-year from $445000.0 in Q1 2024.
Jade Biosciences (JBIO) Current Leases (2021 - 2025) Analysis & Trends
Jade Biosciences' Current Leases history runs 5 years deep, the most recent figure standing at $312000.0 for Q1 2025.
- Quarterly Current Leases fell 29.89% year-over-year to $312000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $312000.0 (down 29.89% YoY) and the FY2024 annual result came in at $417000.0, down 0.71% from the prior year.
- Current Leases was $312000.0 for Q1 2025 at Jade Biosciences, down from $417000.0 in the prior quarter.
- Across five years, Current Leases topped out at $475000.0 in Q2 2024 and bottomed at $147000.0 in Q3 2021.
- A 5-year average of $358266.7 and a median of $379000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases jumped 157.82% — and 2025, when it decreased 29.89%.
- Jade Biosciences' Current Leases stood at $192000.0 in 2021, then jumped by 100.52% to $385000.0 in 2022, then gained by 9.09% to $420000.0 in 2023, then declined by 0.71% to $417000.0 in 2024, then fell by 25.18% to $312000.0 in 2025.
- Business Quant data shows JBIO's Current Leases at $312000.0 in Q1 2025, $417000.0 in Q4 2024, and $459000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 451,000.00 |
| Jun 30, 2023 | 379,000.00 |
| Mar 31, 2023 | 373,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 347,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 192,000.00 |
| Sep 30, 2021 | 147,000.00 |